The University of Missouri in Columbia announced a series of investments totaling $20.5 million in innovative research projects, the majority of which will support the university system's NextGen Precision Health Initiative and Institute.
The investments include $11 million from the system and a combined $9.5 million from the four individual campuses. Of the 19 projects receiving funding, 13 will advance the efforts of NextGen, which launched in June and which Mun Choi, PhD, the system's president, labeled "our highest priority" in a statement about the new investments.
Among the 13 projects supporting the precision medicine institute are ones that will develop a computational hub to analyze and store massive datasets; discover novel therapies to kill cancer tumors while preserving healthy tissue; and increase understanding of heart failure progression in Duchenne muscular dystrophy patients.
More articles on health IT:
How to leverage digital components of the EHR, optimize performance and value
Cleveland Clinic chair Beth Mooney: 'You've got to lean into the digital world'
California hospital to implement Cerner EHR: 4 notes